Sirona Historical Balance Sheet

SBM Stock

CAD 0.06 0.00 0.00%

Trend analysis of Sirona Biochem Corp balance sheet accounts such as Net Tangible Assets of 202.7 K, Accounts Payable of 1.3 M, Cash of 987 K or Long Term Debt of 1.9 M provides information on Sirona Biochem's total assets, liabilities, and equity, which is the actual value of Sirona Biochem Corp to its prevalent stockholders. By breaking down trends over time using Sirona Biochem balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Sirona Biochem Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sirona Biochem Corp is a good buy for the upcoming year.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sirona Biochem Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Sirona Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Sirona Biochem Corp at a specified time, usually calculated after every quarter, six months, or one year. Sirona Biochem Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Sirona Biochem and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Sirona currently owns. An asset can also be divided into two categories, current and non-current.

Sirona Biochem Balance Sheet Chart

At this time, Sirona Biochem's Total Current Liabilities is fairly stable compared to the past year. Net Tangible Assets is likely to climb to about 202.7 K in 2025, whereas Other Current Liabilities is likely to drop slightly above 103.5 K in 2025.

Total Assets Other Current Liab Total Current Liabilities Other Liab

Total Assets

Total assets refers to the total amount of Sirona Biochem assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Sirona Biochem Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Sirona Biochem balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Sirona Biochem Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Sirona Biochem's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Sirona Biochem Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sirona Biochem Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2024	2025 (projected)
Other Current Liabilities	175.3K	201.6K	103.5K
Total Assets	1.3M	928.9K	882.4K

Other Current Liab Total Assets

Sirona Biochem balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Net Receivables	Short Term Investments	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Non Current Assets Total	Non Current Liabilities Total	Capital Lease Obligations	Net Debt
Total Assets		-0.38	-0.69	0.92	0.01	0.51	0.7	-0.61	0.49	-0.55	0.49	0.27	0.33	0.48	-0.57	0.29	-0.36	0.55	-0.34	0.46	-0.59	0.33	0.74	-0.22	0.72	0.2
Other Current Liab	-0.38		0.6	-0.44	0.26	0.13	-0.64	0.49	0.09	0.28	-0.57	-0.47	-0.53	-0.2	0.5	0.02	0.3	-0.03	0.2	-0.53	0.68	-0.46	-0.42	-0.04	-0.65	-0.28
Total Current Liabilities	-0.69	0.6		-0.87	-0.02	-0.19	-0.67	0.8	-0.02	0.83	-0.41	-0.38	-0.5	-0.52	0.82	-0.43	0.57	-0.09	0.45	-0.64	0.57	-0.43	-0.66	0.44	-0.72	-0.05
Total Stockholder Equity	0.92	-0.44	-0.87		-0.04	0.47	0.74	-0.71	0.3	-0.8	0.38	0.35	0.49	0.54	-0.82	0.26	-0.51	0.37	-0.43	0.6	-0.63	0.36	0.78	-0.5	0.73	0.1
Other Liab	0.01	0.26	-0.02	-0.04		-0.06	-0.13	0.12	0.02	0.18	0.05	-0.27	-0.44	0.4	0.1	0.07	-0.26	-0.01	-0.27	-0.44	0.11	-0.16	-0.01	-0.04	-0.07	-0.06
Net Tangible Assets	0.51	0.13	-0.19	0.47	-0.06		-0.07	0.12	0.66	-0.19	-0.33	0.18	0.1	-0.02	-0.28	-0.04	-0.45	0.66	-0.49	0.11	0.16	-0.03	0.11	-0.29	-0.19	-0.41
Retained Earnings	0.7	-0.64	-0.67	0.74	-0.13	-0.07		-0.63	-0.16	-0.62	0.63	0.45	0.71	0.7	-0.6	0.08	-0.29	-0.07	-0.28	0.75	-0.95	0.34	0.88	-0.11	0.92	0.64
Accounts Payable	-0.61	0.49	0.8	-0.71	0.12	0.12	-0.63		-0.08	0.72	-0.59	-0.22	-0.25	-0.3	0.63	-0.59	0.09	-0.16	-0.07	-0.47	0.55	-0.37	-0.5	0.37	-0.8	-0.11
Cash	0.49	0.09	-0.02	0.3	0.02	0.66	-0.16	-0.08		0.08	0.06	-0.2	-0.3	-0.17	-0.01	0.1	-0.03	0.97	0.02	-0.24	0.2	-0.1	-0.18	-0.07	-0.04	-0.51
Long Term Debt	-0.55	0.28	0.83	-0.8	0.18	-0.19	-0.62	0.72	0.08		-0.13	-0.33	-0.6	-0.5	0.87	-0.31	0.47	0.04	0.34	-0.73	0.53	-0.22	-0.62	0.69	-0.57	0.0
Net Receivables	0.49	-0.57	-0.41	0.38	0.05	-0.33	0.63	-0.59	0.06	-0.13		-0.11	0.18	0.43	-0.14	0.19	0.01	0.14	0.03	0.23	-0.61	0.21	0.44	0.29	0.79	0.5
Short Term Investments	0.27	-0.47	-0.38	0.35	-0.27	0.18	0.45	-0.22	-0.2	-0.33	-0.11		0.57	0.1	-0.36	0.18	-0.35	-0.06	-0.37	0.65	-0.4	0.14	0.33	-0.07	0.27	0.22
Other Current Assets	0.33	-0.53	-0.5	0.49	-0.44	0.1	0.71	-0.25	-0.3	-0.6	0.18	0.57		0.44	-0.54	-0.18	-0.49	-0.24	-0.52	0.89	-0.66	0.11	0.58	-0.12	0.47	0.38
Other Stockholder Equity	0.48	-0.2	-0.52	0.54	0.4	-0.02	0.7	-0.3	-0.17	-0.5	0.43	0.1	0.44		-0.46	0.05	-0.49	-0.17	-0.52	0.51	-0.68	0.0	0.69	-0.14	0.58	0.45
Total Liab	-0.57	0.5	0.82	-0.82	0.1	-0.28	-0.6	0.63	-0.01	0.87	-0.14	-0.36	-0.54	-0.46		-0.03	0.59	-0.09	0.41	-0.61	0.61	-0.29	-0.61	0.78	-0.53	0.07
Deferred Long Term Liab	0.29	0.02	-0.43	0.26	0.07	-0.04	0.08	-0.59	0.1	-0.31	0.19	0.18	-0.18	0.05	-0.03		0.08	0.11	0.1	0.2	0.04	0.16	0.09	0.07	0.31	-0.03
Short Long Term Debt	-0.36	0.3	0.57	-0.51	-0.26	-0.45	-0.29	0.09	-0.03	0.47	0.01	-0.35	-0.49	-0.49	0.59	0.08		-0.11	0.95	-0.44	0.27	0.23	-0.32	0.35	-0.13	0.2
Total Current Assets	0.55	-0.03	-0.09	0.37	-0.01	0.66	-0.07	-0.16	0.97	0.04	0.14	-0.06	-0.24	-0.17	-0.09	0.11	-0.11		-0.05	-0.17	0.11	-0.11	-0.13	-0.1	0.03	-0.47
Short Term Debt	-0.34	0.2	0.45	-0.43	-0.27	-0.49	-0.28	-0.07	0.02	0.34	0.03	-0.37	-0.52	-0.52	0.41	0.1	0.95	-0.05		-0.45	0.23	0.26	-0.34	0.14	-0.06	0.05
Intangible Assets	0.46	-0.53	-0.64	0.6	-0.44	0.11	0.75	-0.47	-0.24	-0.73	0.23	0.65	0.89	0.51	-0.61	0.2	-0.44	-0.17	-0.45		-0.7	0.15	0.63	-0.13	0.58	0.37
Common Stock	-0.59	0.68	0.57	-0.63	0.11	0.16	-0.95	0.55	0.2	0.53	-0.61	-0.4	-0.66	-0.68	0.61	0.04	0.27	0.11	0.23	-0.7		-0.29	-0.82	0.13	-0.86	-0.65
Property Plant Equipment	0.33	-0.46	-0.43	0.36	-0.16	-0.03	0.34	-0.37	-0.1	-0.22	0.21	0.14	0.11	0.0	-0.29	0.16	0.23	-0.11	0.26	0.15	-0.29		0.47	-0.09	0.45	0.3
Non Current Assets Total	0.74	-0.42	-0.66	0.78	-0.01	0.11	0.88	-0.5	-0.18	-0.62	0.44	0.33	0.58	0.69	-0.61	0.09	-0.32	-0.13	-0.34	0.63	-0.82	0.47		-0.22	0.8	0.65
Non Current Liabilities Total	-0.22	-0.04	0.44	-0.5	-0.04	-0.29	-0.11	0.37	-0.07	0.69	0.29	-0.07	-0.12	-0.14	0.78	0.07	0.35	-0.1	0.14	-0.13	0.13	-0.09	-0.22		-0.07	0.43
Capital Lease Obligations	0.72	-0.65	-0.72	0.73	-0.07	-0.19	0.92	-0.8	-0.04	-0.57	0.79	0.27	0.47	0.58	-0.53	0.31	-0.13	0.03	-0.06	0.58	-0.86	0.45	0.8	-0.07		0.56
Net Debt	0.2	-0.28	-0.05	0.1	-0.06	-0.41	0.64	-0.11	-0.51	0.0	0.5	0.22	0.38	0.45	0.07	-0.03	0.2	-0.47	0.05	0.37	-0.65	0.3	0.65	0.43	0.56

Click cells to compare fundamentals

Sirona Biochem Account Relationship Matchups

Sirona Biochem balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.1M	1.3M	1.3M	1.0M	928.9K	882.4K
Other Current Liab	102.1K	105.8K	105.8K	175.3K	201.6K	103.5K
Total Current Liabilities	1.0M	741.2K	864.5K	1.9M	2.1M	2.3M
Total Stockholder Equity	47.4K	(97.0K)	214.5K	(2.5M)	(2.3M)	(2.1M)
Other Liab	102.9K	121.6K	130.6K	115.1K	132.4K	117.8K
Net Tangible Assets	2.2M	47.4K	(97.0K)	214.5K	193.1K	202.7K
Retained Earnings	(35.5M)	(37.8M)	(41.4M)	(43.9M)	(39.5M)	(37.5M)
Accounts Payable	620.5K	297.4K	315.6K	1.1M	1.3M	1.3M
Cash	1.5M	778.0K	421.5K	571.5K	657.2K	987.0K
Long Term Debt	850.4K	468.8K	91.1K	1.5M	1.8M	1.9M
Net Receivables	107.2K	55.9K	23.9K	6.6K	5.9K	5.6K
Other Stockholder Equity	(11.4K)	(101.5K)	(61.3K)	(224.1K)	(201.7K)	(191.6K)
Total Liab	2.1M	1.4M	1.1M	3.5M	4.1M	2.1M
Short Long Term Debt	264.2K	300.7K	337.7K	637.7K	733.3K	536.1K
Total Current Assets	2.1M	1.3M	1.3M	1.0M	1.2M	1.7M
Common Stock	28.5M	29.1M	31.2M	34.5M	39.7M	21.5M
Non Current Assets Total	37.3K	27.8K	18.7K	9.0K	8.1K	7.7K
Non Current Liabilities Total	1.1M	643.3K	211.7K	1.7M	1.5M	897.2K
Capital Lease Obligations	127.3K	81.1K	41.4K	5.9K	5.3K	5.0K
Common Stock Shares Outstanding	226.3M	236.1M	251.7M	253.6M	291.6M	242.2M
Net Invested Capital	1.2M	672.5K	643.3K	(334.3K)	(300.9K)	(285.8K)
Net Working Capital	1.1M	518.5K	407.4K	(843.5K)	(759.2K)	(721.2K)
Capital Stock	29.1M	31.2M	34.5M	34.7M	39.9M	32.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Sirona Stock Analysis

When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sirona Historical Balance Sheet

About Sirona Balance Sheet Analysis

Sirona Biochem Balance Sheet Chart

Total Assets

Total Current Liabilities

Sirona Biochem balance sheet Correlations

Sirona Biochem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sirona Biochem balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Sirona Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 0.97	Cash
Short Term Debt	+ 0.95	Short Long Term Debt
Total Stockholder Equity	+ 0.92	Total Assets
Capital Lease Obligations	+ 0.92	Retained Earnings
Intangible Assets	+ 0.89	Other Current Assets
Non Current Assets Total	+ 0.88	Retained Earnings

Common Stock	- 0.95	Retained Earnings
Total Stockholder Equity	- 0.87	Total Current Liabilities
Capital Lease Obligations	- 0.86	Common Stock
Non Current Assets Total	- 0.82	Common Stock
Total Liab	- 0.82	Total Stockholder Equity
Capital Lease Obligations	- 0.8	Accounts Payable